Home › NDC Lookup › RxCUI directory › RxCUI 1493510

{1 (28000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel [Clear Proof Acne Treatment]) / 1 (... — RxCUI 1493510

RxNorm drug concept · Brand name pack
RxCUI 1493510 Brand name pack · BPCK ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1493510
Official name{1 (28000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel [Clear Proof Acne Treatment]) / 1 (127000 MG) (salicylic acid 20 MG/ML Medicated Liquid Soap [Clear Proof Acne Medication]) / 1 (147 ML) (salicylic acid 20 MG/ML Topical Solution [Clear Proof Acne Medication]) } Pack [Clear Proof Acne System]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asClear Proof Acne System Kit; MARY KAY clear proof acne system Pack; {1 (1 OZ.) (Benzoyl Peroxide 5 % Topical Gel [Clear Proof Acne Treatment]) / 1 (4.5 OZ.) (Salicylic Acid 2 % Medicated Liquid Soap [Clear Proof Acne Medication]) / 1 (5 FL. OZ.) (Salicylic Acid 2 % Topical Solution [Clear Proof Acne Medication]) } Pack [Clear Proof Acne System]; Mary Kay Clear Proof Acne System Kit
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Benzoyl Peroxide Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Over-the-counter products are used for acne. The prescription product EPSOLAY is used for inflammatory lesions of rosacea in adults.
  • Do a test on one or two small areas for the first 3 days if you are new to an over-the-counter product. If it feels fine, apply a thin layer once daily and increase to two or three...
  • Redness, dryness, peeling, itching and burning or stinging are common. Using it less often can help. Stop and call your doctor if irritation becomes severe.
  • It's best not to. Using more than one topical acne medicine at a time makes irritation and dryness more likely. If irritation develops, use only one.
📖 Read our full Benzoyl Peroxide Topical guide →

🕸️ Concept Web — How {1 (28000 MG) (benzoyl peroxide 0.05 MG/MG Topic... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {1 (28000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel [Clear Proof Acne Treatment]) / 1 (127000 MG) (salicylic acid 20 MG/ML Medicated Liquid Soap [Clear Proof Acne Medication]) / 1 (147 ML) (salicylic acid 20 MG/ML Topical Solution [Clear Proof Acne Medication]) } Pack [Clear Proof Acne System] RxCUI 1493510

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Benzoyl peroxide 1418
    • Salicylic acid 9525
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Clear Proof Acne Medication 1491644
    • Clear Proof Acne Treatment 1489128
  3. Dose forms 15

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzoyl peroxide Topical Gel 377955
    • Salicylic acid Medicated Liquid Soap 562599
    • Salicylic acid Topical Solution 238464
    • Benzoyl peroxide Topical Product 1152991
    • Salicylic acid Soap Product 1295375
    • Salicylic acid Topical Product 1157604
    • Benzoyl peroxide Topical Gel [Clear Proof Acne Treatment] 1489130
    • Salicylic acid Medicated Liquid Soap [Clear Proof Acne Medication] 1493163
    • +7 more in this family
  4. Clinical & branded drugs 10

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 21 of 30 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1493510 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51531-8977-00 1 KIT in 1 CARTON (51531-8977-0) * 147 mL in 1 BOTTLE * 1... Clear Proof Acne System Mary Kay Inc. 2013-08-15
Observed labelers: Mary Kay Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.